Pol Plus500 mg+65 mg

Pol Plus is an over-the-counter analgesic-antipyretic combination widely used for the short-term relief of mild-to-moderate pain and fever.

Established uses

• Headache, including tension-type headache
• Toothache
• Backache and minor musculoskeletal aches and pains
• Period pain (dysmenorrhea)
• Sore throat pain
• Fever and generalized aches associated with the common cold and influenza

Adjunct use

Pol Plus is also used as an adjunct in the symptomatic relief of migraine headache; caffeine is added to enhance the analgesic effect of paracetamol and to help counter the fatigue and drowsiness that often accompany headache and migraine, rather than to treat migraine on its own.

Each tablet/caplet of Paracetamol + Caffeine typically contains Paracetamol (Acetaminophen) 500 mg combined with Caffeine (anhydrous) in the range of approximately 30 mg to 65 mg, depending on the manufacturer's formulation. Exact strengths vary by brand, so the product label should always be checked.

Pol Plus is a fixed-dose combination of two active ingredients: paracetamol (acetaminophen), a widely used non-opioid analgesic and antipyretic, and caffeine, a central nervous system stimulant included at a sub-stimulant dose to act as an analgesic adjuvant.

Pol Plus is available without a prescription in Bangladesh and many other countries as tablets or caplets, and is commonly used for everyday aches, headache, and fever.

Non-opioid analgesic and antipyretic combination — Pol Plus (para-aminophenol derivative combined with a xanthine-derivative CNS stimulant used as an analgesic adjuvant)

Paracetamol + Caffeine combines two complementary mechanisms of action:

• Paracetamol is believed to act mainly through central inhibition of prostaglandin synthesis (predominantly via a central cyclooxygenase pathway) and modulation of the descending serotonergic pain pathway, producing analgesic and antipyretic effects with only weak peripheral anti-inflammatory activity. It reduces fever by acting on the hypothalamic heat-regulating center.
• Caffeine is a methylxanthine that acts mainly as a competitive adenosine-receptor antagonist. At the low dose used in this combination it does not independently relieve pain, but it enhances the analgesic efficacy of paracetamol, speeds the onset of pain relief, and causes mild cerebral vasoconstriction, which is thought to be helpful in headache and migraine. It also counters the drowsiness and fatigue that often accompany pain and fever.

Together, the components in Paracetamol + Caffeine provide faster and more effective relief of headache and other mild-to-moderate pain than paracetamol alone.

Take Pol Plus tablets orally with a full glass of water. It may be taken with or without food, although taking it with food may reduce stomach upset in sensitive individuals. Do not crush or chew unless the product is specifically formulated to allow this. Swallow the tablet whole.

• Warfarin and other oral anticoagulants: Regular or high-dose use of the paracetamol component of Pol Plus may enhance the anticoagulant effect of warfarin, increasing bleeding risk; patients on warfarin should consult a physician before regular use.
• Enzyme-inducing anticonvulsants (e.g., phenytoin, carbamazepine, barbiturates): These may increase the metabolism of paracetamol to hepatotoxic metabolites, increasing the risk of liver damage even at standard doses.
• Metoclopramide and domperidone: May increase the rate and extent of paracetamol absorption.
• Cholestyramine: May reduce the absorption of paracetamol if taken together.
• Chronic alcohol use: Increases the risk of paracetamol-related liver toxicity (see Precautions and Warnings).
• Other caffeine-containing products (coffee, tea, energy drinks, cola, other analgesics containing caffeine): Concurrent use adds to total caffeine intake and may increase the risk of nervousness, insomnia, and palpitations.

Pol Plus is generally well tolerated at recommended doses. Reported side effects include:

• Nausea or mild stomach upset (uncommon)
• Skin rash, itching, or urticaria (uncommon; discontinue if a skin reaction occurs)
• Nervousness, restlessness, insomnia, or palpitations, related to the caffeine component, particularly with higher intake or in caffeine-sensitive individuals
• Rare but serious hematological reactions (e.g., thrombocytopenia, leukopenia, agranulocytosis) have been reported very rarely with long-term paracetamol use
• Serious liver injury with overdose or chronic excessive use (see Overdose and Precautions)

Pregnancy: Paracetamol, the primary analgesic in Pol Plus, is generally considered acceptable for short-term use at recommended doses during pregnancy when clearly needed, but Pol Plus should be used only if the potential benefit justifies the potential risk, and a physician should be consulted before use. The caffeine component means that total caffeine intake from Pol Plus plus all other dietary sources (coffee, tea, cola, energy drinks) should be kept within the limits recommended in pregnancy by a treating physician, as high caffeine intake has been associated with adverse pregnancy outcomes in some studies.

Lactation: Both paracetamol and caffeine pass into breast milk in small amounts. Pol Plus is generally considered compatible with breastfeeding when used at recommended doses for short periods, but a physician or pharmacist should be consulted, and the breastfed infant should be monitored for unusual irritability or poor sleep.

• Hepatotoxicity risk: The paracetamol component of Pol Plus can cause severe, potentially fatal liver damage if the maximum recommended daily dose is exceeded, if used for longer than recommended, or if combined with any other paracetamol-containing product. Always check other medicines for paracetamol content before combining.
• Alcohol and liver disease: Chronic alcohol use and pre-existing liver disease increase the risk of hepatotoxicity with Pol Plus; such patients should consult a physician before use and should not exceed the lowest effective dose.
• Caffeine-related effects: Pol Plus may cause insomnia, nervousness, restlessness, or palpitations, especially with excessive intake or in caffeine-sensitive individuals. Additional caffeine from coffee, tea, cola, or energy drinks should be limited while using Pol Plus.
• Renal impairment: Use with caution in patients with significant renal impairment (see Use in Special Populations).
• Duration of use: Do not use continuously for more than 10 days for pain (5 days in children) or 3 days for fever without consulting a physician; persistent or worsening symptoms warrant medical review.

Overdose of Pol Plus is a medical emergency, primarily because of the paracetamol component. Early symptoms of paracetamol overdose (nausea, vomiting, sweating, abdominal pain, general malaise) may be mild, absent, or non-specific for the first 24 hours even when a serious, potentially fatal overdose has occurred; severe liver damage typically becomes apparent only after 1–2 days, by which time treatment is less effective. Caffeine overdose can cause marked nervousness, tremor, rapid heartbeat, and, rarely, seizures.

In case of a known or suspected overdose of Pol Plus, seek immediate medical attention or contact a poison control center/emergency services right away, even if the person appears well or has no symptoms. Do not wait for symptoms to appear before seeking help, as early treatment significantly improves outcomes.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

• Elderly: Use the lowest effective dose of Pol Plus for the shortest duration necessary; monitor for signs of hepatic or renal impairment, which may be more common in this age group.
• Hepatic impairment: Use with caution and at reduced dose/frequency in mild-to-moderate hepatic impairment; contraindicated in severe hepatic impairment (see Contraindications).
• Renal impairment: Use with caution in moderate-to-severe renal impairment; dosing interval may need to be increased on medical advice.
• Children: See Pediatric Uses.

Pol Plus is intended for short-term, symptomatic use only. Adults should not use it for more than 10 consecutive days for pain, or more than 3 days for fever, without consulting a physician. In children, treatment for pain should generally not exceed 5 days without medical advice. If symptoms persist, worsen, or recur, medical evaluation is required to identify the underlying cause.

Analgesic–antipyretic combination: a para-aminophenol derivative (paracetamol) combined with a xanthine-derivative CNS stimulant used as an analgesic adjuvant (caffeine)

Paracetamol + Caffeine works through the combined action of its two ingredients. Paracetamol reduces pain and fever by acting centrally, largely through inhibition of prostaglandin synthesis in the central nervous system and modulation of descending pain pathways, along with a central antipyretic action on the hypothalamus. Caffeine, a competitive adenosine-receptor antagonist, does not directly relieve pain at this dose but potentiates the analgesic effect of paracetamol, speeds its onset of action, mildly constricts cerebral blood vessels (helpful in headache), and reduces the drowsiness commonly associated with pain and fever.

Pol Plus is generally not recommended for children under 12 years of age, as the safety and efficacy of this specific fixed-dose combination have not been established in this age group, and caffeine-containing analgesic combinations are not a preferred choice for pediatric pain or fever management.

For children requiring analgesic or antipyretic treatment, a physician-directed, weight-based dose of paracetamol alone is generally preferred. If a physician specifically recommends Pol Plus for a child aged 12 years or older, the adult dosing guidance should be followed unless the physician advises otherwise.